U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07437547) titled 'BPC 157 for Acute Hamstring Muscle Strain Repair' on Feb. 22.
Brief Summary: This randomized, double-blind, placebo-controlled Phase 2 study evaluates whether pentadecapeptide BPC 157 (BPC-157), an investigational peptide, can speed structural healing and functional recovery after an acute grade II hamstring muscle strain. Participants will receive BPC 157 or placebo for 14 days in addition to a standardized rehabilitation program. The co-primary endpoints are time to return to unrestricted sport and change in MRI-assessed injury volume at Day 14.
Study Start Date: Feb. 02
Study Type: INTERVENTIONAL
Condition:
Hamstring Muscle S...